Here are three things to know.
1. The organizations will use Optum’s claims and clinical records data to create and assess valued-based prescription payment models.
2. Optum and Merck will publicly share their assessments of the payment models “to help inform and facilitate the understanding and use of pragmatic approaches to [outcomes-based risk sharing agreements] in the healthcare system.
3. The partnership is the latest in a growing number of valued-based reimbursement collaborations for prescription drug payments.
- Bloomfield, Con.-based Cigna has entered seven outcomes-based deals since 2009, according to Bloomberg.
- Danish drugmaker Novo Nordisk recently signed its first pay-for-performance contract with Louisville, Ky.-based Humana for the diabetes treatment Victoza.
- Novartis, Amgen, Sanofi and Eli Lilly & Co., have also signed similar contracts with various insurers in the past year, according to the report.
More articles on payer issues:
7 questions about UnitedHealth’s false claims lawsuits, answered
How Aetna, Anthem, Humana and UnitedHealth fared in Q1
CMS seeks to remove small business plan enrollment from ACA marketplace: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.